KDL Biotech (Delisted) share news and announcements

BSE: 532291

Formerly Kopran Drugs

Last traded ₹2.14 on 16 Mar 2015

Delisted on 11 May 2018.

KDL Biotech board meetings

50 filed, newest first.

  1. Feb 2015

    • 3 Feb · Board meeting

      Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held February 10, 2015: (1) To transact the following business: 1. To consider and approve Un-audited Financial Results for the quarters ended June 30, 2013, September 30, 2013, December 31, 2013, March 31, 2014, June 30, 2014, September 30, 2014 & December 31, 2014. 2. To consider and approve Annual Accounts for the financial year ended March 31, 2013. 3. To consider fixing the date of convening the Annual General Meeting of the Members of the Company. The Company has now informed the Exchange that the due to unavailable reason the Board Meeting of the company which was scheduled to be held on February 10, 2015 has been rescheduled on February 12, 2015.

      Not held on this date

  2. Jan 2015

    • 29 Jan · Board meeting

      To transact the following business: 1. To consider and approve Un-audited Financial Results for the quarters ended June 30, 2013, September 30, 2013, December 31, 2013, March 31, 2014, June 30, 2014, September 30, 2014 & December 31, 2014. 2. To consider and approve Annual Accounts for the financial year ended March 31, 2013. 3. To consider fixing the date of convening the Annual General Meeting of the Members of the Company.
  3. May 2013

  4. Feb 2013

    • 13 Feb · Board meeting

      Mr. Nihar Ranjan Das has resigned from the post of Company Secretary of the Company. Further, Mr. Manish Bhojwani has been appointed as Company Secretary of the Company with effect from February 08, 2013. Mr. Manish Bhojwani has been designated as Compliance Officer of the Company.
    • 11 Feb · Board meeting

      Company had informed the Exchange regarding a Board meeting to be held on February 08, 2013 to consider inter alia the Un-audited Financial Results of the Company for the quarter ended December 31, 2012. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled to February 13, 2013.

      Not held on this date

  5. Jan 2013

  6. Nov 2012

    • 5 Nov · Board meeting

      To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended September 30, 2012.
  7. Aug 2012

    • 25 Aug · Board meeting

      Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on August 24, 2012 to transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2012; (2) Any other matter with the permission of the Chair. The Company has now informed the Exchange that due to lack of quorum the aforesaid Board Meeting has been adjourned and will now be held on August 28, 2012.
    • 21 Aug · Board meeting

      To transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2012; (2) Any other matter with the permission of the Chair.
    • 6 Aug · Board meeting

      To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended June 30, 2012.
  8. May 2012

    • 15 May · Board meeting

      Company had informed the Exchange regarding Meeting of the Board of Directors of the Company scheduled to be held May 14,2012 to consider inter-alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2012. The Company has now informed the Exchange that the Board Meeting of the Company which was scheduled to be held on May 14, 2012 for considering inter-alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2012 has been adjourned to May 15, 2012 for clarifications on certain accounting items.
    • 5 May · Board meeting

      To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2012.
  9. Feb 2012

    • 7 Feb · Board meeting

      To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended December 31, 2011.
  10. Nov 2011

    • 3 Nov · Board meeting

      To consider inter alia the half year and quarter ended September 30, 2011 Un-audited Financial Results of the Company.
  11. Aug 2011

    • 19 Aug · Board meeting

      Board of Directors of the Company in their Meeting held on August 17, 2011 has transacted the following business: (1) Fixed date of Annual General Meeting as September 28, 2011 and approved the notice of Annual General Meeting.(2) Accepted the Resignation given by Mr. Harish Bhardwaj, Director of the Company from the Board of Directors.
    • 18 Aug · Board meeting

      Board of Directors of the Company at its meeting held on August 17, 2011, has transacted the following business: 1. Fixed the date of twenty-fourth ....
    • 12 Aug · Board meeting

      Company had informed the Exchange regarding Meeting of the Board of Directors of the Company scheduled to be held on August 12, 2011 to transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2011; (2) To Consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2011; (3) Any other matter with the permission of the Chair. The Company has now informed the Exchange that the Board Meeting of the Company which was scheduled to be held on August 12, 2011 has been adjourned due to lack of qorum and the same will now be held on August 17, 2011.
    • 3 Aug · Board meeting

      To transact the following business : (1) To take on record Audited Financial Results for the Accounting Period ended on March 31, 2011; (2) To Consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2011; (3) Any other matter with the permission of the Chair.
  12. May 2011

    • 12 May · Board meeting

      Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 12, 2011 to consider inter alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2011. The Company has now informed the Exchange that the aforesaid Board Meeting which was held on May 12, 2011 has been adjourned and will be held on May 13, 2011.
    • 2 May · Board meeting

      To consider inter alia the Un-audited Financial Results of the Company for the quarter ended March 31, 2011.
  13. Feb 2011

    • 4 Feb · Board meeting

      To consider inter alia the Un-audited Financial Results of the Company for the quarter ended December 31, 2010.
  14. Nov 2010

    • 4 Nov · Board meeting

      Kdl Biotech Ltd has now informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2010, have approved the revised draft of code of conduct for prevention ....
  15. Oct 2010

    • 8 Oct · Board meeting

      To consider inter alia the Un-audited Financial Results of the Company for the quarter ended September 30, 2010.
  16. Aug 2010

  17. Jul 2010

    • 31 Jul · Board meeting

      To consider inter alia the Un-audited Financial Results of the Company for the first quarter ended June 30, 2010.
    • 13 Jul · Board meeting

      Company had convened Meeting of Board of Directors on July 12, 2010. As sufficient directors to form a quorum as per section 287(2) of the Companies Act 1956 were not present, the meeting was adjourned for want of quorum to July 16, 2010.
    • 8 Jul · Board meeting

      To transact the following business : (1) To take on record Audited Financial Results for the Accounting Period (18 months) ended on March 31, 2010; (2) Any other matter with the permission of the Chair.
  18. Apr 2010

    • 22 Apr · Board meeting

      Meeting on 29 Apr 2010: “Unaudited Financial Results for the qtr ended March 31, 2010”
  19. Jan 2010

    • 21 Jan · Board meeting

      Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
  20. Oct 2009

    • 15 Oct · Board meeting

      Meeting on 31 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
  21. Jul 2009

    • 13 Jul · Board meeting

      Meeting on 30 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
  22. Apr 2009

    • 21 Apr · Board meeting

      Meeting on 29 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
  23. Jan 2009

    • 28 Jan · Board meeting

      Meeting of the Board of Directors of the Company was held on December 31, 2008. In the said meeting the Board of Directors has transacted the following business. 1) Recommended the draft Balance Sheet & profit & Loss Account for the Accounting Year ( 12 months ) ended September 30, 2008 to the Shareholders for their approval at the ensuing AGM; 2) Recommended for shareholders approval the draft Auditors report on the accounts of the Company for the Accounting Year (12 months) ended September 30, 2008. 3) Recommended for shareholders approval the draft Directors Report for the Accounting Year (12months) ended September 30, 2008. 4) Recommended for shareholders approval the draft Corporate Governance Report for the Accounting Year ( 12 months ) ended September 30, 2008;and 5) Approved the draft Notice of Annual General Meeting of the Company.
    • 22 Jan · Board meeting

      Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
  24. Dec 2008

    • 22 Dec · Board meeting

      To transact the following business: (1) To take on record Audited Financial Results for the Year ended September 30, 2008; (2) Any other matter with the permission of the Chair.
  25. Sep 2008

    • 11 Sep · Board meeting

      Board of Directors of the Company in their Meeting held on September 11, 2008 have allotted 72,72,727 Equity Shares of the company to Unimark Remedies Ltd. for cash at a price of Rs.12/- per Share (i.e. face value of Rs. 10/- and a premium of Rs. 2/- per share) on preferential basis. In view of the allotment of 72,72,727 equity shares of the Company to Unimark Remedies Limited on preferential basis, the Paid-up Share Capital of the Company has been increased from the existing Rs. 1676.24 lacs to Rs. 2403.51 lacs.
    • 10 Sep · Board meeting

      To consider and approve the allotment of 72,72,727 equity shares of the Company to Unimark Remedies Limited for cash at a price of Rs. 12/- per share (i.e. Face value Rs. 10/- and a premium of Rs. 2/- per share) on Preferential basis.
  26. Aug 2008

    • 22 Aug · Board meeting

      Outcome of the Board Meeting held on 22/8/2008 :- " (1) Mr. Nihar Ranjan Das has been appointed as the Company Secretary of the Company with effect from 11/8/2008. (2) Un-audited Financial Results for the quarter ended 31/3/2008 has not been placed before the Board, as the same is pending for review with the Statutory Auditors M/s. Khandelwal Jain & Co, Chartered Accountants, Mumbai. (3) Draft Limited Review Report for the quarter ended 31/3/2008 has not been placed before the Board, as we have not received the said Draft from the Statutory Auditors duly approved."
    • 22 Aug · Board meeting

      To consider inter-alia Un-audited Financial Results for the quarter ended March 31,2008 and June 30,2008 and also the Draft Limited Review reports for both the said Quarters.
    • 19 Aug · Board meeting

      Company had informed the Exchange regarding the Board Meeting to be held on April 30, 2008 to consider inter-alia the Unaudited Financial Results of the Company for the quarter ended March 31, 2008. Further, as company was not able to place before the Board the Un-audited Financial Results of the Company for the quarter ended March 31, 2008 due to the following reasons, the meeting was adjourned:- (1) Major problem occurred as data lost including back-up due to failure of ERP System integrated with Tally Package. As a result, reconciliation of stores/excise/customs data from intra-department is badly affected. Retrieval of data is still in the process. (2) Resignation of Officials handling accounts. (3) Recruitment of the Officials in place of the Officials who have tendered resignation is taking time. The Company has now informed the Exchange that as the Un-audited Financial Results for the above quarter along with Draft Limited Review Report is available and would like to place the same before the Board, Company is therefore calling the aforesaid adjourned Board Meeting, which is scheduled to be held on August 22, 2008, for considering the Un-audited Financial Results of the Company for the quarter ended March 31, 2008 and the Limited Review Report for the said quarter.
  27. Jul 2008

    • 22 Jul · Board meeting

      To review the financial status of the Company.
    • 15 Jul · Board meeting

      To discuss routine matter.
  28. Apr 2008

    • 23 Apr · Board meeting

      Meeting on 30 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
  29. Jan 2008

    • 17 Jan · Board meeting

      Meeting on 25 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
  30. Dec 2007

    • 14 Dec · Board meeting

      To transact the following business : 1) To take on record Un-audited Financial Results for the quarter ended 30th September 2007. 2) To take on record Audited Financial Results for the eighteen month Year ended 30th September 2007. 3) Any other matter.
  31. Nov 2007

    • 28 Nov · Board meeting

      To transact the following business : 1) To take on record Un-audited Financial Results for the quarter ended 30th September 2007. 2) To take on record Audited Financial Results for the eighteen month Year ended 30th September 2007. 3) Any other matter.
  32. Jul 2007

    • 19 Jul · Board meeting

      To transact the following business: (1) To take on record Un-Audited Financial Results for the quarter ended June 30, 2007. (2) Any other matter.
  33. Apr 2007

    • 19 Apr · Board meeting

      To transact the following business; (1) to take on record Un-Audited Financial Results for the quarter ended March 31, 2007. (2) to take on record resignation of Director. (3) to approve & appoint the Additional Director. (4) any other matter.
  34. Jan 2007

    • 23 Jan · Board meeting

      Meeting on 25 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”